NCT01519336View on ClinicalTrials.gov

A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

danoprevir

100 mg q12h

DRUG

darunavir

600 mg q12h

DRUG

ritonavir

100 mg q12h

Trial Locations (1)

66219

Lenexa

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01519336 - A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers | Biotech Hunter | Biotech Hunter